{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:40:04Z","timestamp":1784068804249,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T00:00:00Z","timestamp":1621382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002380"],"award-info":[{"award-number":["TL1 TR002380"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Mayo Clinic Office for Health Disparities"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s40615-021-01059-8","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T18:14:23Z","timestamp":1621448063000},"page":"1184-1191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Perceptions of Ethnoracial Factors in the Management and Treatment of Uterine Fibroids"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0152-7117","authenticated-orcid":false,"given":"Minerva","family":"Orellana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0127-9555","authenticated-orcid":false,"given":"Kirsten A.","family":"Riggan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3230-5100","authenticated-orcid":false,"given":"Karen","family":"DSouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1110-2400","authenticated-orcid":false,"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sateria","family":"Venable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3497-1115","authenticated-orcid":false,"given":"Joyce E.","family":"Balls-Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-9256","authenticated-orcid":false,"given":"Megan A.","family":"Allyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,19]]},"reference":[{"issue":"17","key":"1059_CR1","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","volume":"372","author":"EA Stewart","year":"2015","unstructured":"Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med. 2015;372(17):1646\u201355.","journal-title":"N Engl J Med"},{"issue":"5","key":"1059_CR2","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jpsychores.2014.12.016","volume":"78","author":"M Ghant","year":"2015","unstructured":"Ghant M, et al. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health. J Psychosom Res. 2015;78(5):499\u2013503.","journal-title":"J Psychosom Res"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejogrb.2018.07.032","volume":"229","author":"F Herve","year":"2018","unstructured":"Herve F, et al. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Eur J Obstet Gynecol Reprod Biol. 2018;229:32\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"1059_CR4","doi-asserted-by":"publisher","first-page":"211 e1","DOI":"10.1016\/j.ajog.2011.12.002","volume":"206","author":"ER Cardozo","year":"2012","unstructured":"Cardozo ER, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206(3):211 e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/IJWH.S133212","volume":"9","author":"M Fuldeore","year":"2017","unstructured":"Fuldeore M, Soliman A. Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis. Int J Women's Health. 2017;9:403\u201311.","journal-title":"Int J Women's Health"},{"issue":"1","key":"1059_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1059_CR7","doi-asserted-by":"publisher","first-page":"591.e1","DOI":"10.1016\/j.ajog.2018.09.039","volume":"219","author":"O Yu","year":"2018","unstructured":"Yu O, et al. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. Am J Obstet Gynecol. 2018;219(6):591.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1059_CR8","doi-asserted-by":"crossref","unstructured":"Murji A, et al. Influence of ethnicity on clinical presentation and quality of life in women with uterine fibroids: results from a prospective observational registry. J Obstet Gynaecol Can. 2019;42(6):726\u201333.","DOI":"10.1016\/j.jogc.2019.10.031"},{"issue":"11","key":"1059_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1089\/jwh.2018.7076","volume":"27","author":"EE Marsh","year":"2018","unstructured":"Marsh EE, et al. Burden, prevalence, and treatment of uterine fibroids: a survey of U.S. women. J Women's Health (Larchmt). 2018;27(11):1359\u201367.","journal-title":"J Women's Health (Larchmt)"},{"issue":"2","key":"1059_CR10","first-page":"84","volume":"36","author":"JE Balls-Berry","year":"2017","unstructured":"Balls-Berry JE, Acosta-P\u00e9rez E. The use of community engaged research principles to improve health: community academic partnerships for research. P R Health Sci J. 2017;36(2):84\u20135.","journal-title":"P R Health Sci J"},{"issue":"4","key":"1059_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/1475-6773.12275","volume":"50","author":"G Foley","year":"2015","unstructured":"Foley G, Timonen V. Using grounded theory method to capture and analyze health care experiences. Health Serv Res. 2015;50(4):1195\u2013210.","journal-title":"Health Serv Res"},{"issue":"10","key":"1059_CR12","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/jwh.2013.4334","volume":"22","author":"E Stewart","year":"2013","unstructured":"Stewart E, et al. The burden of uterine fibroids for African-American women: results of a national survey. J Women's Health (Larchmt). 2013;22(10):807\u201316.","journal-title":"J Women's Health (Larchmt)"},{"issue":"4","key":"1059_CR13","doi-asserted-by":"publisher","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","volume":"209","author":"B Borah","year":"2013","unstructured":"Borah B, et al. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209(4):319.e1\u2013319.e20.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"1059_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4755-11-10","volume":"11","author":"L Brito","year":"2014","unstructured":"Brito L, et al. Uterine leiomyoma: understanding the impact of symptoms on womens' lives. Reprod Health. 2014;11(1):10.","journal-title":"Reprod Health"},{"issue":"2","key":"1059_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s40615-016-0216-1","volume":"4","author":"K Sengoba","year":"2017","unstructured":"Sengoba K, et al. Racial\/ethnic differences in women's experiences with symptomatic uterine fibroids: a qualitative assessment. J Racial Ethn Health Disparities. 2017;4(2):178\u201383.","journal-title":"J Racial Ethn Health Disparities"},{"issue":"1","key":"1059_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/AOG.0000000000002990","volume":"133","author":"A Alexander","year":"2019","unstructured":"Alexander A, et al. Examining disparities in route of surgery and postoperative complications in Black race and hysterectomy. Obstet Gynecol. 2019;133(1):6\u201312.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1059_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12913-017-2471-1","volume":"17","author":"WR Robinson","year":"2017","unstructured":"Robinson WR, et al. For U.S. Black women, shift of hysterectomy to outpatient settings may have lagged behind White women: a claims-based analysis, 2011-2013. BMC Health Serv Res. 2017;17(1):526.","journal-title":"BMC Health Serv Res"},{"key":"1059_CR18","first-page":"CD004638","volume":"10","author":"P Bhave Chittawar","year":"2014","unstructured":"Bhave Chittawar P, et al. Minimally invasive surgical techniques versus open myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2014;10:CD004638.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1059_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/AOG.0000000000002738","volume":"132","author":"NC Stentz","year":"2018","unstructured":"Stentz NC, Cooney LG, Sammel MD, Shah DK. Association of patient race with surgical practice and perioperative morbidity after myomectomy. Obstet Gynecol. 2018;132(2):291\u20137.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"1059_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jmig.2017.03.016","volume":"24","author":"A Ranjit","year":"2017","unstructured":"Ranjit A, Sharma M, Romano A, Jiang W, Staat B, Koehlmoos T, et al. Does universal insurance mitigate racial differences in minimally invasive hysterectomy. J Minim Invasive Gynecol. 2017;24(5):790\u20136.","journal-title":"J Minim Invasive Gynecol"},{"issue":"5","key":"1059_CR21","doi-asserted-by":"publisher","first-page":"572.e1","DOI":"10.1016\/j.ajog.2017.07.036","volume":"217","author":"J Price","year":"2017","unstructured":"Price J, et al. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease. Am J Obstet Gynecol. 2017;217(5):572.e1\u2013572.e10.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"1059_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajog.2015.03.019","volume":"213","author":"AM Soliman","year":"2015","unstructured":"Soliman AM, Yang H, du EX, Kelkar SS, Winkel C. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015;213(2):141\u201360.","journal-title":"Am J Obstet Gynecol"},{"issue":"1-a Suppl","key":"1059_CR23","first-page":"S2","volume":"26","author":"A Harrington","year":"2020","unstructured":"Harrington A, et al. Direct costs incurred among women undergoing surgical procedures to treat uterine fibroids. J Manag Care Spec Pharm. 2020;26(1-a Suppl):S2\u2013s10.","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"1059_CR24","first-page":"56","volume":"14","author":"BR Kennedy","year":"2007","unstructured":"Kennedy BR, Mathis CC, Woods AK. African Americans and their distrust of the health care system: healthcare for diverse populations. J Cult Divers. 2007;14(2):56\u201360.","journal-title":"J Cult Divers"},{"issue":"2","key":"1059_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/08964289.2019.1585327","volume":"45","author":"W Powell","year":"2019","unstructured":"Powell W, Richmond J, Mohottige D, Yen I, Joslyn A, Corbie-Smith G. Medical mistrust, racism, and delays in preventive health screening among African-American men. Behav Med. 2019;45(2):102\u201317.","journal-title":"Behav Med"},{"issue":"7","key":"1059_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2105\/AJPH.2005.080762","volume":"97","author":"K Armstrong","year":"2007","unstructured":"Armstrong K, Ravenell KL, McMurphy S, Putt M. Racial\/ethnic differences in physician distrust in the United States. Am J Public Health. 2007;97(7):1283\u20139.","journal-title":"Am J Public Health"},{"key":"1059_CR27","doi-asserted-by":"publisher","unstructured":"Cuevas AG, O'Brien K, Saha S. African American experiences in healthcare: \u201cI always feel like I\u2019m getting skipped over\u201d. Health Psychol. 2016. https:\/\/doi.org\/10.1037\/hea0000368.","DOI":"10.1037\/hea0000368"},{"key":"1059_CR28","doi-asserted-by":"crossref","unstructured":"Townes A, et al. \u2018Somebody that looks like me\u2019 matters: a qualitative study of black women\u2019s preferences for receiving sexual health services in the USA. Cult Health Sex. 2020;30:1\u201315.","DOI":"10.1080\/13691058.2020.1818286"},{"issue":"3","key":"1059_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/13557858.2018.1439896","volume":"25","author":"L Rosenthal","year":"2020","unstructured":"Rosenthal L, Lobel M. Gendered racism and the sexual and reproductive health of Black and Latina Women. Ethn Health. 2020;25(3):367\u201392.","journal-title":"Ethn Health"},{"issue":"1","key":"1059_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/heq.2017.0045","volume":"2","author":"C Prather","year":"2018","unstructured":"Prather C, Fuller TR, Jeffries WL IV, Marshall KJ, Howell AV, Belyue-Umole A, et al. Racism, African American women, and their sexual and reproductive health: a review of historical and contemporary evidence and implications for health equity. Health Equity. 2018;2(1):249\u201359.","journal-title":"Health Equity"},{"issue":"2","key":"1059_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3122\/jabfm.2014.02.120314","volume":"27","author":"MN Oliver","year":"2014","unstructured":"Oliver MN, Wells KM, Joy-Gaba JA, Hawkins CB, Nosek BA. Do Physicians' implicit views of African Americans affect clinical decision making? J Am Board Fam Med. 2014;27(2):177\u201388.","journal-title":"J Am Board Fam Med"},{"issue":"8","key":"1059_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1089\/jwh.2015.5531","volume":"25","author":"M Ghant","year":"2016","unstructured":"Ghant M, et al. An altered perception of normal: understanding causes for treatment delay in women with symptomatic uterine fibroids. J Women's Health (Larchmt). 2016;25(8):846\u201352.","journal-title":"J Women's Health (Larchmt)"},{"issue":"6","key":"1059_CR33","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.fertnstert.2017.09.018","volume":"108","author":"M Bray","year":"2017","unstructured":"Bray M, et al. Admixture mapping of uterine fibroid size and number in African American women. Fertil Steril. 2017;108(6):1034\u20131042.e26.","journal-title":"Fertil Steril"},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fgene.2019.00511","volume":"10","author":"T Edwards","year":"2019","unstructured":"Edwards T, et al. A trans-ethnic genome-wide association study of uterine fibroids. Front Genet. 2019;10:511.","journal-title":"Front Genet"},{"issue":"3","key":"1059_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/EDE.0b013e31828acca0","volume":"24","author":"D Baird","year":"2013","unstructured":"Baird D, et al. Vitamin d and the risk of uterine fibroids. Epidemiology. 2013;24(3):447\u201353.","journal-title":"Epidemiology"},{"issue":"S1","key":"1059_CR36","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.2105\/AJPH.2018.304844","volume":"109","author":"AF Brown","year":"2019","unstructured":"Brown AF, Ma GX, Miranda J, Eng E, Castille D, Brockie T, et al. Structural interventions to reduce and eliminate health disparities. Am J Public Health. 2019;109(S1):S72\u20138.","journal-title":"Am J Public Health"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-021-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-021-01059-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-021-01059-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T15:35:52Z","timestamp":1656689752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-021-01059-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,19]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s40615-021-01059-8","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,19]]},"assertion":[{"value":"18 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Mayo Clinic Institutional Review Board has approved this study Going FAR: Uterine Fibroids and Reproduction under IRB#: 17-010494.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"We obtained written informed consent from participants in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"We have obtained HIPAA authorization from participants and de-identified participant information in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors MO, KR, KD, and MA report no conflicts of interest. EAS, JBB, and SV report additional funding from the Agency for Healthcare Research and Quality grant P50HS023418. JBB reports consultation with Boston Scientific and Parabon NanoLabs, Inc. EAS reports consulting for AbbVie, Bayer, ObsEva, and Myovant related to uterine fibroids and payment for development of educational content from UpToDate, Med Learning Group, PER, and Peer View. SV reports consulting for AbbVie, Myovant, Bayer.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}